"The Effect of the Cord Clamping Bundle at Birth Developed With the Delphi Method on Maternal and Newborn Outcomes"
Starting soon · Not applicable
Conditions studied: Effects of a Cord Clamping Bundle on Maternal and Neonatal Outcomes
In brief
This clinical trial aims to evaluate the effects of a cord clamping bundle developed through the Delphi method on maternal and neonatal outcomes. The study population consists of primiparous women with singleton term pregnancies (37-42 weeks of gestation) who undergo vaginal delivery, along with their healthy newborns. The primary research questions are: Does the Delphi-based cord clamping bundle improve maternal and neonatal physiological outcomes? Does the Delphi-based cord clamping bundle enhance mother-infant bonding and breastfeeding success? Comparison Group: Researchers will compare the intervention group, in which the cord clamping bundle is implemented, with the control group receiving routine clinical care to determine the effects of the intervention on maternal and neonatal outcomes. Participant Involvement: Participants will provide written and verbal informed consent and complete a personal information form. Following delivery, participants will receive either the cord clamping bundle intervention or routine care according to their assigned group. Data collection will be conducted within the first 24 hours postpartum and will include: Maternal and neonatal physiological parameters Breastfeeding success assessed using the LATCH Breastfeeding Assessment Tool Mother-infant bonding assessed using the Mother-to-Infant Bonding Scale Amount of postpartum bleeding Placental separation time Time to initiation of breastfeeding Length of hospital stay after delivery.
Key facts
- Study ID
- NCT07701434
- Run by
- Elif MARANGOZ
- People needed
- 100
- Starts
- 2026-07-01
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2026-07-14
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Primiparous women Singleton pregnancy Term pregnancy (37-42 weeks of gestation) Vaginal delivery Healthy newborn Mother and newborn discharged together Age 18 years or older Willingness to participate and provide written informed consent
You may not qualify if…
- High-risk pregnancy Maternal chronic disease Maternal or neonatal conditions affecting breastfeeding Newborn with intrauterine growth restriction (IUGR) Newborn with a genetic disorder or congenital anomaly Operative or assisted vaginal delivery requiring obstetric intervention Refusal to participate or withdrawal from the study Incomplete study data or inability to complete outcome assessments
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.